More Business Wire
View Older Stories View Newer Stories-
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
-
Students Plan Walkout in Support of Striking Support Workers
-
Boston-Based Code Metal Hosts Hackathon for United States Special Operations Command
-
Laser Photonics, Fonon Technologies & Brokk Expand Nuclear Decontamination Alliance
-
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors
-
Newrez Earns Fannie Mae’s Prestigious Servicer Total Achievement and Rewards™ (STAR™) Performer Recognition for 2024
-
Pivotree to Release Fourth Quarter 2024 Financial Results
-
EYSA and Palantir Partner to Enhance Mobility Application Development
-
Macy’s, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results
-
AECOM declares quarterly dividend
-
The Buckle, Inc. Reports February 2025 Net Sales and Announces Fourth Quarter Earnings Conference Call
-
BJ’s Wholesale Club Holdings, Inc. Announces Fourth Quarter and Full Fiscal 2024 Results
-
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
-
Myers Industries Announces Fourth Quarter and Full Year 2024 Results
-
Turning Point Brands Announces Fourth Quarter and Full Year 2024 Results
-
MarketAxess Announces Trading Volume Statistics for February 2025
-
Global Blue Releases the Monthly Tax Free Shopping Business Update for February 2025
-
SK Capital Partners Acquires Physical Properties Testers (“PPT”) Group Limited From Battery Ventures
-
Venture Global Reports Fourth Quarter and Full Year 2024 Results
-
Shoe Carnival to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 20, 2025
-
GMS Reports Third Quarter Fiscal 2025 Results
-
Sam Erdheim Appointed as Head of Marketing at Radiant Logic
-
Draslovka expands into sodium-ion batteries in partnership with U.S. Manufacturer Natron Energy
-
New McAfee Research Reveals Scammers Love Tax Season—And They’re Cashing In: 51% of Victims Lose Over $1,000
-
PHAXIAM Therapeutics: Press Release Regarding Suspension of Trading
-
Dynacor Refuses to Call Requisitioned Special Meeting – iolite calls Meeting for April 9, 2025
-
Pierre & Vacances-Center Parcs: Total Number of Shares and Voting Rights
-
ProFrac Holding Corp. Reports Full Year and Fourth Quarter 2024 Results
-
Italfarmaco Provides Overview on Givinostat as Treatment for Duchenne Muscular Dystrophy: Progress in Global Access, Regulatory Milestones and Clinical Trials
-
Axelera AI Secures up to €61.6 Million Grant to Develop Scalable AI Chiplet for High-Performance Computing
-
State Street Onboards River Global to its Transfer Agency Service Supported by ZILO™
-
Magellan Aerospace Partners With Aequs Private Limited to Explore Setting Up a Sand Casting Facility in India
-
AlTi Tiedemann Global Expands European Presence and enters Germany with Acquisition of Kontora
-
UMC Reports Sales for February 2025
-
CF Benchmarks Adds Crypto.com Exchange to Leading CME CF Bitcoin and Ether Reference Rates
-
Powder Unleashes First-Ever AI-Powered, NPU-Accelerated Video Editing for Gamers
-
FPT Becomes Sitecore Reseller Partner, Strengthening Strategic Presence in Asia-Pacific
-
MUFG Bank, Ltd. Announces Notice Regarding Changes of Representatives of the Board of Directors
-
Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025
-
Slate Asset Management Completes More Than €420 Million of Essential Real Estate Acquisitions in Germany Year to Date
-
GoldenPeaks Capital Signs Power Purchase Agreement With NGK Ceramics Polska
-
EOLO Chooses Thales to Expand High-Speed Internet Access in Italy
-
Maurel & Prom: 2024 Annual Results
-
Getlink SE: Shuttle Traffic in February 2025
-
Getlink: Annual Results 2024: EBITDA Target Achieved at €833 Million Driven by the Performance of the Group's Core Businesses
-
HAFNIA LIMITED: Mandatory Notification of Trade by Close Associate of Primary Insider
-
Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency¹, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Traject
-
FDJ UNITED: Very Strong 2024 Results
-
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
-
Azelis Group NV: Integrated Report 2024.
